Seeing Is Believing
Currently out of the existing stock ratings of Mayank Mamtani, 199 are a BUY (88.44%), 25 are a HOLD (11.11%), 1 are a SELL (0.44%).
Analyst Mayank Mamtani works with a stock forecast success ratio of 30.69% fulfilled within 125.24 days on average. Previously, Mayank Mamtani worked at B. RILEY.
Mayank Mamtani’s has documented 445 price targets and ratings displayed on 33 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on MDGL, Madrigal Pharmaceuticals at 27-Feb-2024.
Analyst best performing recommendations are on INMB (INMUNE BIO).
The best stock recommendation documented was for ALT (ALTIMMUNE) at 11/9/2023. The price target of $8 was fulfilled within 39 days with a profit of $5.55 (226.53%) receiving and performance score of 58.08.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
2.5
$-0.28 (-10.07%)
1 years 1 months 13 days ago
1/1 (100%)
$1.86 (290.63%)
145
Buy
30
1 years 9 months 6 days ago
0/1 (0%)
$22.32 (290.63%)
Buy
3 years 6 months 26 days ago
0/1 (0%)
$59.52 (163.16%)
Which stock is Mayank Mamtani is most bullish on?
Which stock is Mayank Mamtani is most reserved on?
What Year was the first public recommendation made by Mayank Mamtani?